index
At Novartis, we are reimagining medicine
Novartis 2020 Financial Results
Novartis announced fourth quarter and full year financial results for 2020 on January 26, 2021.
COVID-19 US Information Center
Novartis is responding to the coronavirus disease (COVID-19) outbreak. The information center provides a central hub for news, guidance and resources.
Novartis US at a Glance
Learn more about Novartis in the US and our impact on patients, families and their communities.
Notice to Healthcare Providers and Entities
Novartis enters into Corporate Integrity Agreement with Office of Inspector General (OIG) of the US Department of Health & Human Services.
Working Together at Novartis to Fight COVID-19 and Help People in Need
Novartis is fighting COVID-19 broadly, from committing R&D resources to better understand and treat the disease to reaching out to individuals and communities in need.
AveXis renamed Novartis Gene Therapies, signifying the growing importance of gene therapy to Novartis corporate strategy
Standing for Racial Equity and Justice as One Novartis
We believe unequivocally that Black Lives Matter. As a company focused on improving human health globally, we also recognize the disparities Black communities and communities of color face when it comes to healthcare.